Target intelligence / Profile preview

Multiple endogenous and exogenous antigens

Molecular classification
Other
01

Overview

Multiple endogenous and exogenous antigens refers to a broad and heterogeneous group of molecules that can elicit an immune response. Endogenous antigens include self-proteins, such as those involved in autoimmune reactions or tumor-associated antigens, while exogenous antigens originate from outside the body, including bacteria, viruses, fungi, and toxins (Janeway's Immunobiology). This collective target is most commonly associated with the therapeutic use of Intravenous Immunoglobulin (IVIG), which contains a diverse pool of IgG antibodies capable of binding and neutralizing these various antigens (StatPearls, NBK554446). By interacting with this wide array of targets, IVIG provides passive immunity and exerts anti-inflammatory and immunomodulatory effects. Because it encompasses a vast range of molecular structures rather than a single defined protein, it is considered a collective target category rather than a specific therapeutic target. It is often used in clinical literature to describe the broad-spectrum activity of polyvalent antibody preparations in treating immunodeficiencies and autoimmune disorders.

Other names
Endogenous antigensExogenous antigensSelf and non-self antigensBroad-spectrum antigens
02

Mechanism of action

Neutralization of circulating toxins and pathogens, inhibition of complement-mediated damage, and modulation of Fc receptor expression and function (StatPearls, NBK554446).

03

Biological functions

Immune responsePathogen recognitionAntigen presentationHomeostasis
04

Disease associations

Autoimmune diseaseInfectious diseasePrimary immunodeficiencyInflammatory disorder
05

Safety considerations

Infusion-related reactions (fever, chills)Thromboembolic eventsAcute renal failureAseptic meningitisAnaphylaxis in IgA-deficient patients (StatPearls, NBK554446)
06

Interacting drugs

Intravenous immunoglobulin (IVIG)

1 more in the full profile.

07

Biomarkers

Serum IgG levelsAntigen-specific antibody titersInflammatory markers (e.g., CRP, ESR)

Beyond the preview

Go deeper on Multiple endogenous and exogenous antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple endogenous and exogenous antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call